期刊文献+

血清胃泌素释放肽前体和神经元烯醇化酶在小细胞肺癌早期诊断中的价值及其相关性 被引量:18

Significance and correlation between serum proGRP and NSE in the early diagnosis of small cell lung cancer
下载PDF
导出
摘要 目的探讨胃泌素释放肽前体(progastrinreleasingpeptide,ProGRP)和神经元烯醇化酶(neuronspecificenolase,NSE)在小细胞肺癌(smallcelllungcancer,SCLC)早期诊断中的作用及两种标志物之间的相关性。方法分别应用双抗体夹心ELISA法和电化学发光免疫法测定了63例SCLC、41例良性肺疾病及40例非小细胞肺癌(nonsmallcelllungcancer,NSCLC)患者血清中ProGRP和NSE的水平。结果单个检测ProGRP、NSE及联合检测ProGRP和NSE(ProGRP+NSE)诊断SCLC的特异性分别为88.89%、80.25%及66.67%,敏感性分别为73.02%、63.49%及84.13%;NSCLC中ProGRP和NSE的敏感性分别为12.5%和22.50%;ProGRP+NSE诊断SCLC的敏感性明显高于NSE(P<0.01),但和ProGRP相比,两者差异无显著性(P>0.05);NSE诊断早期SCLC的敏感性仅36.84%,ProGRP及ProGRP+NSE诊断早期SCLC的敏感性分别为63.16%和73.68%,和晚期SCLC(分别为77.27%及88.64%)相比,均无显著性差异(P>0.05);在SCLC中,ProGRP和NSE的相关性较强(χ2=5.00,P<0.05)。结论NSE对SCLC早期诊断价值有限;ProGRP及ProGRP+NSE可能是肺癌分型及SCLC诊断,尤其是早期诊断的较好指标。 Objective To investigate the significance and correlation between serum ProGRP and NSE in the early diagnosis of small cell lung cancer (SCLC). Methods Serum ProGRP and NSE were detected in 63 patients with SCLC, 40 patients with non-small cell lung cancer (NSCLC) and 41 patients with benign lung disease, using sandwich enzyme immunoassay and electrochemiluminescence immunoassay respectively. Results ① The specificity of individual ProGRP and NSE and the combined detection of ProGRP and NSE for the diagnosis of SCLC were 88.89%, 80.25% and 66.67% respectively, and the sensitivity were 73.02%, 63.49% and 84.13%, respectively. ② The sensitivity of ProGRP and NSE for the diagnosis of NSCLC were 12.5% and 22.50%, respectively. ③ In SCLCs, the sensitivity of combined detection of ProGRP and NSE was significantly higher than that of NSE alone (P<0.05), whereas the sensitivity of ProGRP alone and the combination of ProGRP and NSE had no statistical difference (P>0.05). ④ The sensitivity of each of ProGRP and the combination of ProGRP and NSE in early stage SCLC was insignificantly lower than that in late stage SCLC (P>0.05). ⑤ There was a relatively strong correlation between ProGRP and NSE ( χ2 = 5.00 , P< 0.05 ). Conclusion ProGRP alone and the combined measurement of ProGRP and NSE could be better markers for histopathological type of lung cancer and early diagnosis of SCLCs.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2005年第3期247-249,共3页 Journal of Xi’an Jiaotong University(Medical Sciences)
基金 陕西省科技攻关项目[No.2004K13G3(3)]
关键词 肺癌 早期诊断 肿瘤标志物 small cell lung cancer early diagnosis of lung cancer tumor markers
  • 相关文献

参考文献8

  • 1杨德昌,杨拴盈.肺癌诊断及治疗进展[J].中华结核和呼吸杂志,2004,27(1):18-19. 被引量:44
  • 2Shibayama T, Ueoka H, Nishii K, et al. Complementary roles of pro-gastrin-releasing peptide(ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small cell lung cancer(SCLC) [J]. Lung Cancer, 2001,32(1):61-69. 被引量:1
  • 3余秉翔,刘庆锋,陈良安.胃泌素释放肽前体作为小细胞肺癌标记物的临床研究[J].中国肺癌杂志,2003,6(3):209-210. 被引量:16
  • 4Stieber P, Dienemann H, Schalhorn A, et al. Pro-gastrin-releasing peptide (ProGRP)-a useful marker in small cell lung carcinomas [J]. Anticancer Res, 1999,19(4A):2673-2678. 被引量:1
  • 5Molina R. Tumor marker guidelines of the EYGM: how to sensibly use TM in clinical practice [J]. J Tumor Marker Oncol, 2004, 19(4):79-80. 被引量:1
  • 6Lamy P, Grenier J, Kramar A, et al. Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer [J]. Lung Cancer, 2000,29(3):197-203. 被引量:1
  • 7吴京,于方治.胃泌素释放肽前体对小细胞肺癌诊断作用的初探[J].中华结核和呼吸杂志,2000,23(9):570-571. 被引量:6
  • 8Schneider J, Philipp M, Velcovsky HG, et al. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases [J]. Anticancer Res, 2003 23(2A): 885-893. 被引量:1

二级参考文献17

  • 1[1]Shibayama T, Ueoka H, Nishii K, et al. Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC). Lung Cancer,2001,32(1)∶61-69. 被引量:1
  • 2[2]Stieber P, Dienemann H, Schalhorn A, et al. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas. Anticancer Res,1999,19(4A)∶2673-2678. 被引量:1
  • 3[3]Yamaguchi K, Abe K, Kameya T, et al. Production and molecular size heterogeneity of immunoreactive gastrin-releasing peptide in fetal and adult lungs and primary lung tumors. Cancer Res,1983,43(8)∶3932-3939. 被引量:1
  • 4[6]Niho S, Nishiwaki Y, Goto K, et al. Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen. Lung Cancer,2000,27(3)∶159-167. 被引量:1
  • 5[7]Lamy P, Grenier J, Kramar A, et al. Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer. Lung Cancer,2000,29(3)∶197-203. 被引量:1
  • 6Wharton J,Polak JM,Bloom SR,et al.Bombesin-like immunoreactivity in the lung[].Nature.1978 被引量:1
  • 7Yamaguchi K,Abe K,Kameya T,et al.Production and molecular size heterogeneity of immunoreactive gastrin-releasing peptide in fetal and adult lungs and primary lung tumors[].Cancer Research.1983 被引量:1
  • 8Maruno K,Yamaguchi K,Suzuki M,et al.Immunoreactive gastrinreleasing peptide as a specific tumor marker in patients with small cell lung carcinoma[].Cancer Research.1989 被引量:1
  • 9Miyake Y,Kodama T,Yamaguchi K.Pro-gastrin-releasing peptide (3198) is a specific tumor marker in patients with small cell lung carcinoma[].Cancer Research.1994 被引量:1
  • 10Yamaguchi K,Aoyagi K,Urakami K. et al.Enzym-linked immunosorbent assay of pro-gastrin-releasing peptide for small cell lung cancer patients in comparison with neuron-specific enolase measurement[].Japanese Journal of Cancer Research.1995 被引量:1

共引文献59

同被引文献189

引证文献18

二级引证文献143

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部